Regulatory Alerts2026-06-05
Added · Updated
Financial Supervisory Commission Securities and Futures Bureau Daily News (June 5, 2026)
An Cheng Biotechnology Co., Ltd. (OTC-listed, Stock Code 6610) completed the correction of its incomplete filing for a cash capital increase of 18,000,000 new shares with a total amount of NT$180,000,000 on June 3, 2026. Consequently, the seven-business-day review period for the effectiveness of this filing restarts from the date of correction, with effectiveness expected on June 8, 2026, assuming no major anomalies. No securities investment trust fund cases were approved, effective, or stopped on June 5, 2026.
More like this from FSC
FSC published 10 documents in the last 30 days. We email you each new one the day it's published.
Topics
Share